UPMC Invests Over $3 Million in Six Innovative Health Tech Projects via Pittsburgh Health Data Alliance

Recently, the University of Pittsburgh Medical Center (UPMC) issued a statement announcing its plan to invest in six healthcare projects affiliated with the Pittsburgh Health Data Alliance. Co-hosted by the University of Pittsburgh and Carnegie Mellon University, the alliance aims to drive innovation in the healthcare sector through the use of big data. The investment, totaling more than $3 million, is scheduled to be completed within the next six months. Currently, the UPMC Foundation is conducting commercial viability assessments for these projects.

Advancing Pittsburgh’s Healthcare Industry Through Innovative Ideas

“We are delighted to work alongside the latest high-quality initiative within the Health Data Alliance,” said Tal Heppenstall, Chairman of UPMC. “This investment advances the Alliance’s mission to leverage innovative ideas to transform the entrenched mindsets of Pittsburgh’s esteemed scientists, physicians, and entrepreneurs regarding the healthcare industry.”

Among the projects included in this investment, one was developed by Carnegie Mellon University’s Center for Mechanical Health Research, while the other five are projects from the University of Pittsburgh’s Center for Commercial Applications of Healthcare Data.


Introduction to Funded Projects

1. Clinical Genomic Model Platform

This project was developed by the Mechanical and Health Research Institute at Carnegie Mellon University. The product is a precision medicine model platform designed for specific patient populations and diseases. For instance, the platform provides a prioritization mechanism to assist healthcare institutions in determining whether a patient can be discharged for home-based treatment under physician supervision or requires admission to the intensive care unit (ICU).

2、MEDIvate

MEDIvate is a mobile application designed to help users update and share their medication lists in real time. Patients can manually enter their medication information or download it directly into the app from the hospital’s cloud-based information system.

3. TDI System

This software is a system that provides oncologists with patients' tumor genetic information.

4、Fall Sentinel

This application is designed for use after patients are discharged and return home, enabling clinical pharmacists to continue providing medication guidance through the system while simultaneously monitoring adverse drug reactions in real time.

5、Pump

This project is an early warning system that leverages wearable devices and hospital bed sensors to monitor patients’ disease onset in real time.

6、ComPACD

This project is a software solution that assists pathologists in streamlining and analyzing complex cancer imaging data to enable precise disease diagnosis.

In addition, earlier this year, the University of Pittsburgh Medical Center invested in Lantern, a company headquartered in San Francisco, USA, whose project involves delivering cognitive behavioral therapy for anxiety disorders via website and mobile applications.

Meanwhile, in early March 2016, UPMC led a $35 million investment round in medCPU, a clinical decision support company.

VCBeat previously reported on UPMC’s investment activities. For details regarding UPMC’s investment in medCPU, please visit http://www.vcbeat.top/29277.html

Additionally,For more information about the University of Pittsburgh Medical Center, please refer to VCBeat’s previous report: “America’s Best Hospitals: How the University of Pittsburgh Medical Center Achieved $12 Billion”Revenuehttp://www.vcbeat.top/28804.html